Immunogen Inc. (IMGN) announced after the bell Wednesday that it intends to sell 13,000,000 shares of its common stock in an underwritten public offering. The stock is now down 0.63 on 73K shares.
Immunogen climbed during the second half of the morning Wednesday and ended the day with a gain of 0.18 at $7.83.
For comments and feedback contact: editorial@rttnews.com
Business News